Gleevec, a drug used to treat leukemia, costs $70,000 a year in the US but only $2,500 in India. This costly gap exists thanks to US patents that prevent competitors from making and selling lower cost versions. Such patents do not exist to the same extent in India, and, in fact, just this month India’s … Continue reading Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India